1. Home
  2. DNLI vs IVT Comparison

DNLI vs IVT Comparison

Compare DNLI & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • IVT
  • Stock Information
  • Founded
  • DNLI 2013
  • IVT 2005
  • Country
  • DNLI United States
  • IVT United States
  • Employees
  • DNLI N/A
  • IVT N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • IVT Real Estate Investment Trusts
  • Sector
  • DNLI Health Care
  • IVT Real Estate
  • Exchange
  • DNLI Nasdaq
  • IVT Nasdaq
  • Market Cap
  • DNLI 2.2B
  • IVT 2.1B
  • IPO Year
  • DNLI 2017
  • IVT N/A
  • Fundamental
  • Price
  • DNLI $14.93
  • IVT $27.62
  • Analyst Decision
  • DNLI Strong Buy
  • IVT Hold
  • Analyst Count
  • DNLI 13
  • IVT 6
  • Target Price
  • DNLI $32.64
  • IVT $32.20
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • IVT 550.1K
  • Earning Date
  • DNLI 11-03-2025
  • IVT 10-28-2025
  • Dividend Yield
  • DNLI N/A
  • IVT 3.45%
  • EPS Growth
  • DNLI N/A
  • IVT 1421.59
  • EPS
  • DNLI N/A
  • IVT 1.51
  • Revenue
  • DNLI N/A
  • IVT $293,020,000.00
  • Revenue This Year
  • DNLI N/A
  • IVT $9.58
  • Revenue Next Year
  • DNLI $94,232.03
  • IVT $6.83
  • P/E Ratio
  • DNLI N/A
  • IVT $18.25
  • Revenue Growth
  • DNLI N/A
  • IVT 9.60
  • 52 Week Low
  • DNLI $10.57
  • IVT $25.21
  • 52 Week High
  • DNLI $33.33
  • IVT $31.65
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.86
  • IVT 39.95
  • Support Level
  • DNLI $15.53
  • IVT $26.81
  • Resistance Level
  • DNLI $17.02
  • IVT $29.07
  • Average True Range (ATR)
  • DNLI 0.79
  • IVT 0.65
  • MACD
  • DNLI -0.19
  • IVT -0.05
  • Stochastic Oscillator
  • DNLI 0.71
  • IVT 23.41

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

Share on Social Networks: